Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00608530 · ClinicalTrials.gov registry record · NA

Telehealth Outreach for Chronic Back Pain

A NA study of Pain and Back Pain, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
127
Enrollment target
1
Study location

NCT00608530: Completed NA study of Pain and Back Pain, sponsored by VA Office of Research and Development.

NCT00608530 is a NA study of Pain and Back Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 127 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00608530, a NA study of Pain and Back Pain, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
127 participants
Enrollment target
1
Study location

Study Summary

Two separate double double blind, randomized, parallel groups, two-arm, 8 week clinical trials with 6-moth follow-up were conducted using identical inclusion/exclusion criteria and assessment batteries. In both studies patients had chronic low back pain of non-neoplastic origin. In both studies patients were randomized to one of two conditions, either a Cognitive Behavioral-based Therapy or a control condition, a supportive (Rogerian) psychotherapy. Both the cognitive-behavioral and supportive psychotherapy conditions consisted of home-based, telephone supported treatment, with 10 hours of contact time delivered over 8 weeks. In the first study (Study 1) the behavioral and Rogerian interventions were delivered by a licensed psychologist. In the second (Study 2) the interventions were delivered by a medical primary care nurse.

Primary Outcome

The Roland and Morris is a 24-item self-report measure of interference of back pain on everyday function at the present time. Each item is qualified by the phrase "because of my back pain" (e.g., "Because of my back I walk more slowly than usual . . . ; Because of my back I lie down to rest more often"). Scoring the measure involves summing the number of items endorsed (from 0 to 24). Lower scores indicate less disability.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy-Psychologist-Delivered
  • BEHAVIORAL Supportive Psychotherapy-Psychologist-Delivered
  • BEHAVIORAL Cognitive Behavioral Therapy Nurse-Delivered
  • BEHAVIORAL Supportive Psychotherapy-Nurse-Delivered

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 127 participants
Start Date 2008-03
Est. Completion 2015-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT00608530 record still lists

NCT00608530 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (58% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Behavioral Therapy-Psychologist-Delivered is the first listed.

NCT00608530 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00608530 about?

NCT00608530 is a clinical study titled "Telehealth Outreach for Chronic Back Pain". Two separate double double blind, randomized, parallel groups, two-arm, 8 week clinical trials with 6-moth follow-up were conducted using identical inclusion/exclusion criteria and assessment batteries. In both studies patients had chronic low back pain of non-neoplastic origin. In both studies pati...

What is the current status of trial NCT00608530?

This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2008-03. Estimated completion is 2015-12-31.

What conditions does trial NCT00608530 study?

This clinical trial studies the following conditions: Pain, Back Pain.

What interventions are being tested in trial NCT00608530?

The interventions under investigation include: Cognitive Behavioral Therapy-Psychologist-Delivered (BEHAVIORAL), Supportive Psychotherapy-Psychologist-Delivered (BEHAVIORAL), Cognitive Behavioral Therapy Nurse-Delivered (BEHAVIORAL), Supportive Psychotherapy-Nurse-Delivered (BEHAVIORAL).

Who is sponsoring clinical trial NCT00608530?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00608530 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00608530's enrollment target sits among peer trials

127 129th of 374 higher than 246 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03017820 · 127 participants · Phase 1

    A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

  • NCT03609580 · 127 participants · Phase 1

    Post-operative Urinary Retention (POUR) Following Thoracic Surgery

  • NCT06285643 · 127 participants · Phase 2

    A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  • NCT06809400 · 127 participants · Phase 1

    A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00608530, the US trial registry maintained by the National Library of Medicine. NCT00608530 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.